Skip to Content

Brokerages have given Curaleaf Holdings, Inc. (OTCMKTS:CURLF) an average recommendation of “Buy.”

Brokerages have given Curaleaf Holdings, Inc. (OTCMKTS:CURLF) an average recommendation of “Buy.”

According to Bloomberg Ratings, the twelve brokerages currently monitoring Curaleaf Holdings, Inc. (OTCMKTS: CURLF) have given the stock an average rating of “buy,” which indicates that investors should purchase the company’s shares. This information indicates that investors should purchase the company’s shares. In addition, eight research analysts have given the stock a positive recommendation as an investment for the clients’ portfolios. According to brokers who covered the stock in the previous year, the average price target for the stock over the coming year is currently set at $11.72 per share. This is according to the current market price of the stock.
Recently, the company has had comments and suggestions from several analysts. In a research report made public on Friday, December 30, Cantor Fitzgerald lowered their price objective on Curaleaf from $13.00 to $12.00 and gave the company an “overweight” rating. Roth Capital reiterated its “buy” recommendation for investors to consider purchasing Curaleaf stock in a report disseminated on Wednesday, October 26. The company distributed the report. On Tuesday, November 8, Stifel Nicolaus released a report stating that the price goal for Curaleaf had been lowered from C$9.50 to C$8.50. The report was titled “Curaleaf Price Target.” On December 1, Wedbush’s coverage was extended to include Curaleaf, a new addition. They gave the company an “outperform” rating and determined that its price objective should be $8.50. Finally, the “buy” recommendation that Seaport Research Partners has maintained regarding shares of Curaleaf was included in a report released on October 31.
On Friday, the OTCMKTS CURLF market opened for trading with an opening price of $4.22. Over the past 52 weeks, the price of Curaleaf has fluctuated between $3.57 and $9.28 at various points. The stock currently trades at a price that results in a price-to-earnings ratio of -23.44, and the company’s market capitalization has reached $2.61 billion. The debt-to-equity ratio, the current ratio, and the quick ratio all come in at 0.58, but the quick ratio is significantly higher at 0.92. The company’s price over the past fifty days has moved to an average of $5.49, while the price over the past two hundred days has moved to an average of $5.58.
On Monday, November 7, Curaleaf (OTCMKTS: CURLF) announced the results of its most recent quarterly financial report. This report was for the period ending September 30. The company reported a loss of $0.07 per share for the quarter, which was $0.02 lower than the analysts’ consensus estimate, who had anticipated a loss of $0.05 per share for the company’s performance during the quarter. The return on equity and the net margin was in the red for Curaleaf, coming in at negative 7.17% and 9.72%, respectively. The revenue for the quarter came in significantly higher than the consensus expectation of $333.89 million, which came in at $339.73 million instead. The projections of those knowledgeable in this field indicate that during the current fiscal year, Curaleaf will experience a loss equal to -0.19 cents for each share.
The United States of America is the location of the operations of the cannabis business known as Curaleaf Holdings, Inc. This company can be broken down into two categories: the cannabis operations sector and the other operations sector. The cultivation of cannabis, as well as the product’s distribution to the retail and wholesale markets, are both under the purview of the Cannabis Operations section. Non-Cannabis Operations provides medical and adult-use cannabis licensees with expertise in cultivation, processing, and retail, as well as back-office management, intellectual property licensing, real estate leasing services, and financing resources by the terms of management service agreements. This sector is also responsible for providing licensees with access to intellectual property.


Leave a comment

Your email address will not be published. Required fields are marked *